menu
    • menu

    Company profile for Tempus

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therap...
    Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. With the right data, we can accelerate cancer research. We can usher in an era of true precision medicine and revolutionize.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TempusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 W Chicago Ave. Ste 510, Chicago, IL 60654
    Telephone
    Telephone
    833.514.4187
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tempus.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tempuslabs/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tempus Reports Fourth Quarter & Full Year 2025 Results
    Tempus Reports Fourth Quarter & Full Year 2025 Results

    24 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260224126737/en/Tempus-Reports-Fourth-Quarter-and-Full-Year-2025-Results

    BUSINESSWIRE
    24 Feb 2026
    Share Share
    Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
    Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218676812/en/Tempus-Announces-Novel-Pan-Cancer-HRD-RNA-Algorithm

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Tempus Announces Collaboration with Median tech to Screening
    Tempus Announces Collaboration with Median tech to Screening

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212387664/en/Tempus-Announces-Collaboration-with-Median-Technologies-to-Integrate-AI-Powered-Lung-Cancer-Screening-into-the-Pixel-Platform

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Tempus to Report Q4, FY 2025 Results on Feb. 24
    Tempus to Report Q4, FY 2025 Results on Feb. 24

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210337224/en/Tempus-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-24

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Ambry Genetics Reaches 1M RNA Tests, Boosting Accuracy & Yield
    Ambry Genetics Reaches 1M RNA Tests, Boosting Accuracy & Yield

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260202968713/en/Ambry-Genetics-Announces-One-Millionth-Test-Leveraging-RNA-to-Improve-Diagnostic-Accuracy-and-Yield

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Tempus Unveils Ai-Powered IPS Test For Enhanced Immunotherapy
    Tempus Unveils Ai-Powered IPS Test For Enhanced Immunotherapy

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127324978/en/Tempus-Reveals-Its-AI-Driven-IPS-Test-More-Accurately-Predicts-Immunotherapy-Benefit-Compared-to-Conventional-Biomarkers

    BUSINESSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search